Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a Canada-based provider of rapid health screening and remote patient care solutions globally. The Company’s Safe Entry Stations, powered by artificial intelligence AI, use multispectral cameras to analyze physiological data patterns and predict a variety of health issues, including infectious diseases, such as COVID-19, impairment by drugs or alcohol, fatigue, or various mental illnesses. Its remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. Its solutions include Infectious Disease Screening, Impairment Screening, and Mobilewellbeing. The Infectious Disease Screening screen for COVID-19, its variants, and other infectious diseases. It offers cannabis and alcohol impairment screening. Mobilewellbeing is a software platform with patient monitoring devices. The Company’s autonomous, non-invasive, no-contact solutions detect symptoms before they spread through workplace.


CSE:PMED - Post by User

Post by partystockeron Nov 02, 2021 2:41pm
122 Views
Post# 34078554

$CULT appointed pharmacologist to their advisory board

$CULT appointed pharmacologist to their advisory board

CULTFood Science $CULT announced yesterday the appointment of pharmacologist Paul Burridge to their Advisory Board. 


Burridge is the principal of the Burridge Lab at Northwestern University, which is currently studying the use of induced pluripotent stem cells (iPSC) in cultivated meat production. This appointment really adds some weight to $CULT’s team and presents a unique opportunity to be involved with bleeding edge food sciences tech. 


Burridge Labs is responsible for multiple breakthroughs in their field so I’m excited to see how this appointment impacts $CULT’s direction and portfolio moving forward.


Looking forward to hearing more big thing’s from $CULT and can’t wait til they IPO. Hopefully we hear some announcements soon!


https://www.cultfoodscience.com/press-releases/cult-food-science-appoints-pharmacologist-paul-burridge-phd-to-advisory-board

 
<< Previous
Bullboard Posts
Next >>